Aggiornamenti pratici e imparziali in psicofarmacologia

Resta aggiornato con contenuti pratici di psicofarmacologia in audio, video e testo, con crediti CME.

Esplora gli abbonamenti

Ricevi gli aggiornamenti sulla psicofarmacologia nella tua casella di posta

TENDENZE IN PSYCHOPHARMACOLOGY INSTITUTE

Quick Takes

Le ricerche più recenti che contano per la tua pratica clinica. Crediti CME disponibili.

Brain Guides

Guide che sintetizzano la letteratura per prescrivere con sicurezza. Crediti CME disponibili.

Video Lectures

Una selezione di sezioni pratiche dalle nostre Video Lectures. Crediti CME disponibili per i membri Bronze e Silver.

PUBBLICAZIONI RECENTI

Client Repro Course it

Nessun Credito
mohamed.ahamed
Visualizza più info

Aggiornamento di agosto 2026: centanafadina, oveporexton e nuove linee guida su DOC, litio e insonnia

0,75 CME
This guide covers the two first-in-class approvals of mid-2026, centanafadine for ADHD and oveporexton for narcolepsy type 1, alongside new guidance on OCD dosing thresholds, the serum lithium levels that drive renal risk, and the AASM’s ranking of CBT-I against combination treatment for chronic insomnia.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Visualizza più info

Quick Take Vol. 90

0,75 CME
L’esposizione prenatale agli antidepressivi causa autismo o ADHD nella prole? Come si valuta il rischio cardiaco quando si associa un antipsicotico a un SSRI? Quando è opportuno ricominciare la terapia con clozapina dopo un episodio di neutropenia? La schizofrenia dovrebbe essere rinominata? L’aggiunta di ashwagandha alla melatonina migliora il sonno più di ciascun agente da solo?
Docenti: Amanda Koire, M.D., Ph.D., Scott R. Beach, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D.
47,15 minuti in 5 sezioni audio

Farmacoterapia dell’insonnia cronica: una guida pratica

1,0 CME
Una guida pratica alla gestione farmacologica dell’insonnia cronica. Il Dr. Kolla esamina gli antagonisti duali dei recettori dell’oressina, gli Z-drug, le benzodiazepine, la melatonina e il ramelteon, gli antidepressivi sedativi e gli antipsicotici, con indicazioni per la gravidanza, i pazienti anziani e l’uso a lungo termine.
Bhanu Prakash Kolla, M.D.
Mayo Clinic
55,07 minuti in 11 sezioni

Iponatriemia indotta da antidepressivi: meccanismi, rischio, diagnosi e gestione

0,50 CME
This guide gives prescribers an evidence-based approach to antidepressant-associated hyponatremia: how the syndrome of inappropriate antidiuresis (SIAD) develops, which patients to monitor and when, how to recognize symptoms that may mimic depression, and how to manage and apply switching strategies afterward.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Visualizza più info

Quick Take Vol. 89

0,50 CME
Gli antipsicotici possono contribuire a prevenire le recidive della catatonia? Quale antipsicotico aggiuntivo offre i migliori risultati nel trattamento della depressione maggiore? Cosa implicano per la pratica clinica nella schizofrenia le classificazioni aggiornate dell’efficacia degli antipsicotici? Gli agonisti del recettore GLP-1 sono sicuri nei pazienti con disturbi d’ansia in comorbilità? La vareniclina aiuta i pazienti a smettere di svapare?
Docenti: Scott R. Beach, M.D., James Phelps, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.
35,33 minuti in 5 sezioni audio

Esplora la nostra ampia biblioteca di video, sintesi di ricerche e interviste con esperti.

Esplora la nostra biblioteca

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.

This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.

Download Accreditation Information (PDF)

Physicians outside the United States – CME Accreditation Statement

AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2026

Dates: April 1, 2026 – April 1, 2029

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Ti senti disorientato all’inizio della specializzazione in psichiatria?

Accedi GRATUITAMENTE a TUTTI i nostri prodotti per 3 mesi!

Ottieni l’accesso immediato